Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways
about
Structural insights into calcium-bound S100P and the V domain of the RAGE complexS100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE)Receptor for advanced glycation end products and its involvement in inflammatory diseasesInteraction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE)S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domainsBorna disease virus phosphoprotein represses p53-mediated transcriptional activity by interference with HMGB1HBV pathogenesis in animal models: recent advances on the role of plateletsRAGE Expression and ROS Generation in Neurons: Differentiation versus DamageAssociation between HMGB1 and COPD: A Systematic ReviewRole of advanced glycation end products in cellular signalingHigh-mobility group box 1: an amplifier of stem and progenitor cell activity after strokeStructural Basis for Ligand Recognition and Activation of RAGERAGE is a nucleic acid receptor that promotes inflammatory responses to DNATargeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic SteatohepatitisRelationship between Advanced Glycation End Products and Steroidogenesis in PCOSS100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenalHigh mobility group box 1 protein interacts with multiple Toll-like receptorsPurification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end productsAdvanced glycation end products (AGE) induce the receptor for AGE in the colonic mucosa of azoxymethane-injected Fischer 344 rats fed with a high-linoleic acid and high-glucose dietRAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophagesThe high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cellsERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cellsInternalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responsesAmphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE bindingThe high mobility group box chromosomal protein 1 is expressed in the human and rat testis where it may function as an antibacterial factorIdentification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expressionThe receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking sitePhosphoproteome Analysis Reveals Phosphorylation Underpinnings in the Brains of Nurse and Forager Honeybees (Apis mellifera)The sour side of neurodegenerative disorders: the effects of protein glycation.Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signalingCombined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic DisordersMolecular mechanisms of diabetic vascular complicationsControlling the receptor for advanced glycation end-products to conquer diabetic vascular complicationsThe N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation.Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation
P2860
Q21131976-9CEB4B00-C2C2-40E0-9C86-2249D5231883Q21135467-CEC5EA0B-8A78-4C5C-86B9-E7D290935B76Q21285070-A03EB636-A669-4F26-8B82-F91E5AA874F5Q24323192-F852B214-01CC-4136-A2DE-E0320BD4AD59Q24337632-66E3B8EF-B83B-4A5E-8BB0-DF7CDCAB6C04Q24338574-DFDC871D-3306-4A47-9F95-8DD9F5506490Q24648308-50786698-2BBA-4F4B-B210-E01A695430D5Q24672103-D665A061-34F8-48BD-B4C1-61EEA222812CQ26744630-91505034-0AA0-4EEE-A053-FB5CA8EFC0CEQ26770022-305B6352-F7EA-47F9-BCB4-935D0CF43E8EQ27003423-5339446B-EA03-4BC7-948D-0FBBC96A0305Q27008225-DDECB0D1-DDB0-424D-93AD-1363277298C4Q27665039-2B4D4EC4-D6CC-44DD-9646-DD68515BCC0FQ27680115-CAD44155-1F7A-4AA2-A616-DA9BCE824A0DQ28077079-B04F576A-23E5-4C16-B6A2-59D636C71BE0Q28077960-BE590C68-3492-4A9C-8FBA-47F17D24CA6EQ28184570-4AD745A2-3FE5-493F-BF47-26249113A5F8Q28242907-8D230203-18C0-4FF6-9EED-F83A60920CC6Q28280114-534D0910-D273-4402-ABC1-DF061917F46CQ28508886-B19FB925-5844-46E2-8B4A-FEB9AA4FAE8FQ28545019-D506DDE5-4199-42DC-B399-346937ECB549Q28568711-91900107-B2D7-48EF-91F2-F33A39B6B0C0Q28568915-1314A113-43FF-43E8-9EF9-A929D5D9DF5AQ28570659-E2B7129E-10B1-4E6B-9EDE-89118F0195FAQ28574192-383DE50C-3CB1-48F2-B12B-B8B67E00CFBEQ28577725-52813A53-BF66-4EE0-96A9-EBBBCF9AC2A2Q28579193-B44BBE03-DE94-4E62-85B7-B5E4A3201330Q28582285-169DC39B-BC97-4980-A74D-19EC48949A7EQ28590453-0D75A097-22BD-437A-9B5D-DA1C36339DB0Q28645645-B10F033E-DDDE-4089-9EC7-B6BDB1F9D7F3Q29994682-49450C98-BD2B-473A-AC82-DEFB5A827FE5Q30386079-7044AB99-A365-4BEC-9C41-9C0F332FEA42Q30583559-486B13DB-7C34-45A7-B0DD-0D310DC5B770Q33166521-BB8CD076-0C87-4B7C-83D8-D8EB7C878729Q33558421-D59238AB-4105-401D-921B-C1C368F4F209Q33609776-AF600870-9B51-4D36-86F0-0D39B515D976Q33743664-4383BA18-7D5D-4997-9719-91E0CBDC8EF3Q33745462-E6F024E0-6D14-43EE-B072-ED2A28F50BF8Q33850220-A50F183B-3BCC-4F01-AADA-31DCC64ED206Q33851482-556E91B2-80E5-4F06-967F-B4B83DF53BF7
P2860
Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Receptor for advanced glycatio ...... downstream signaling pathways
@ast
Receptor for advanced glycatio ...... downstream signaling pathways
@en
Receptor for advanced glycatio ...... downstream signaling pathways
@en-gb
Receptor for advanced glycatio ...... downstream signaling pathways
@nl
type
label
Receptor for advanced glycatio ...... downstream signaling pathways
@ast
Receptor for advanced glycatio ...... downstream signaling pathways
@en
Receptor for advanced glycatio ...... downstream signaling pathways
@en-gb
Receptor for advanced glycatio ...... downstream signaling pathways
@nl
prefLabel
Receptor for advanced glycatio ...... downstream signaling pathways
@ast
Receptor for advanced glycatio ...... downstream signaling pathways
@en
Receptor for advanced glycatio ...... downstream signaling pathways
@en-gb
Receptor for advanced glycatio ...... downstream signaling pathways
@nl
P2093
P921
P3181
P356
P1476
Receptor for advanced glycatio ...... downstream signaling pathways
@en
P2093
P304
P3181
P356
10.1074/JBC.274.28.19919
P407
P577
1999-07-09T00:00:00Z